Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Related Citations for PubMed (Select 8077800)

1.

The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.

Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.

Int Angiol. 1994 Mar;13(1):59-64.

PMID:
8077800
2.

Beneficial effects of intermittent suction and pressure treatment in intermittent claudication.

Mehlsen J, Himmelstrup H, Himmelstrup B, Winther K, Trap-Jensen J.

Angiology. 1993 Jan;44(1):16-20.

PMID:
8424580
3.

[Positive effect of intermittent overpressure and underpressure (Vacusac) in intermittent claudication].

Mehlsen J, Himmelstrup H, Himmelstrup B, Winther Hansen KF.

Ugeskr Laeger. 1994 Jan 10;156(2):169-71. Danish.

PMID:
8296403
4.

Observations on changes in intermittent claudication after the administration of creatine phosphate.

Favilli S, Iacopetti L, Fradella GA, Righi D, Nuzzaci G.

Pharmatherapeutica. 1982;3(4):221-6.

PMID:
7146037
5.

A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.

Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J.

Eur J Vasc Endovasc Surg. 2006 Mar;31(3):266-73. Epub 2005 Dec 19.

6.

Lack of effect of a 24-hour infusion of iloprost in intermittent claudication.

Hay CR, Waller PC, Carter C, Cameron HA, Parnell L, Ramsay LE, Preston FE, Greaves M.

Thromb Res. 1987 Apr 15;46(2):317-24.

PMID:
2440125
7.

Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.

Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.

Int Angiol. 2001 Dec;20(4):337-44.

PMID:
11782701
8.

A long-term study of policosanol in the treatment of intermittent claudication.

Castaño G, Más Ferreiro R, Fernández L, Gámez R, Illnait J, Fernández C.

Angiology. 2001 Feb;52(2):115-25.

PMID:
11228084
9.

[Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication].

Boccalon H, Lehert P, Mosnier M.

Ann Cardiol Angeiol (Paris). 2001 Apr;50(3):175-82. French.

PMID:
12555510
10.

Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.

Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A.

Angiology. 1984 Jun;35(6):366-72.

PMID:
6375469
11.

[Flunarizine in the treatment of arteriopathies of the legs].

Catalano M, Sacchi E, Tomasini M, Coazzoli E, Parolini A, Dall'Oglio A, Libretti A.

Ric Clin Lab. 1985;15 Suppl 1:475-8. Italian.

PMID:
4035228
12.
13.

Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.

Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS.

Angiology. 2000 Jun;51(6):441-9.

PMID:
10870853
14.

Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.

Mohler ER 3rd, Hiatt WR, Olin JW, Wade M, Jeffs R, Hirsch AT.

J Am Coll Cardiol. 2003 May 21;41(10):1679-86.

PMID:
12767646
15.

Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.

Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC.

J Am Coll Cardiol. 1998 Nov;32(5):1336-44.

16.

[Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].

Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF.

Ugeskr Laeger. 1994 Oct 17;156(42):6207-9. Danish.

PMID:
7998359
17.

Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial.

Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, Goldberg AP.

J Am Geriatr Soc. 2001 Jun;49(6):755-62.

PMID:
11454114
18.

Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.

Mohler ER 3rd, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM.

Vasc Med. 2000;5(4):231-7.

PMID:
11213235
19.

A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease.

Oka RK, Szuba A, Giacomini JC, Cooke JP.

Vasc Med. 2005 Nov;10(4):265-74.

PMID:
16444855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk